Selected projects to receive funding from CASIS and Boeing through the Technology in Space Prize

KENNEDY SPACE CENTER, Fla, November 2, 2021 (CASIS PR) – The Center for the Advancement of Science and Space, Inc. (CASIS) and Boeing [NYSE: BA] are awarding up to $500,000 in grants to two startup companies through the Technology in Space Prize. The startups, krtkl inc. and Oculogenex, Inc., were identified through the MassChallenge (Boston) startup accelerator program. The companies will leverage the International Space Station (ISS) National Laboratory, managed by CASIS, to further their research and technology development in low Earth orbit.

WASHINGTON (NASA PR) — One year ago, NASA announced the agency is opening the space station for business, enabling commercial and marketing opportunities on the station, and the agency has moved forward toward its ultimate goal in low-Earth orbit to partner with industry to achieve a strong ecosystem in which NASA is one of many customers purchasing services and capabilities at lower cost.

Providing expanded opportunities at the International Space Station to manufacture, market and promote commercial products and services will help catalyze and expand space exploration markets for many businesses.

by Douglas Messier
Managing Editor

People with failing eye sight could see their vision restored with the help of NASA-funded research aboard the International Space Station (ISS).

The space agency has selected LamdaVision for a small business award to continue development of a system to manufacture protein-based retinal implants aboard the space station.

FARMINGTON, Conn. (LambdaVision PR)–LambdaVision, an innovative biotech developing a novel treatment to help patients regain sight, along with implementation partner, Space Tango, has been selected by NASA for an award of five million dollars.

This new funding will support LambdaVision’s development of the first protein-based artificial retina to restore meaningful vision for patients who are blind or have lost significant sight due to advanced retinitis pigmentosa (RP), with follow-on applications in age-related macular degeneration (AMD), the leading cause of blindness for adults over 55 years old.

WASHINGTON (NASA PR) — Removing the force of gravity from development processes can lead to products that are higher quality, have fewer defects, and are more effective than when developed on Earth. Companies are demonstrating these improved results can be achieved in the unique microgravity environment on the International Space Station (ISS), which orbits about 250 miles above the planet.

The research opportunities that have demonstrated the unique market value of in-space manufacturing, technology advancement and drug development have come through NASA’s investment in dedicating transportation and research time for ISS National Lab investigations.

BOSTON, MA. (November 7, 2016) – The Center for the Advancement of Science in Space (CASIS) and  Boeing  awarded three research companies financial support last week through MassChallenge™. This marks the third year CASIS and Boeing have collaborated on the “Technology in Space” prize through the MassChallenge Boston Accelerator.

CASIS is the nonprofit organization responsible for managing and promoting research onboard the International Space Station (ISS) U.S. National Laboratory. Boeing is the ISS prime contractor responsible for sustaining operations, including the successful integration of vehicle and payload hardware and software for the orbiting laboratory. The grant prizes for this collaboration will provide seed funding for the three awarded companies and assist with hardware costs for flight to the ISS National Lab.

(more…)